on 08 Feb 2023
Last Applicant/ Owned by
CH-1205 Genève
CH
Serial Number
79128131 filed on 07th Feb 2013
Registration Number
N/A
Correspondent Address
Mathurin BAQUIE; NEURIX SA
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific and technological services, namely, drug efficacy assessment, toxicity testing of chemical and biological compounds, and culture and quality control of human or non-human cells, cell parts and generated biogenic and released parts for non-medical purposes and research and design relating thereto; industrial analysis and research services in the fields of drug efficacy assessment, toxiciRead More
Medical services utilizing chemical and biological compounds, and human or non-human cells, cell parts and generated biogenic and released parts; veterinary services utilizing chemical and biological compounds, cells, cell parts and generated biogenic and released parts; hygienic and beauty care for human beings and animals utilizing chemical and biological compounds, cells, cell parts and generated biogenic and released parts ; agricultural services, namely, application of fertilizers and agricultural agents utilizing chemical and biological compounds; horticulture and horticultural forestry services utilizing chemical and biological compounds and plants and plant elements
Scientific and technological services, namely, drug efficacy assessment, toxicity testing of chemical and biological compounds, and culture and quality control of human or non-human cells, cell parts and generated biogenic and released parts for non-medical purposes and research and design relating thereto; industrial analysis and research services in the fields of drug efficacy assessment, toxicity testing of chemical and biological compounds, and culture and quality control of human or non-human cells, cell parts and generated biogenic and released parts
Surgical apparatus and instruments, medical apparatus and instruments for use in medical diagnosis, prevention, therapy and predictive medicine, and biological apparatus and instruments, namely, syringes for preparation, injection, engraftment and use of human or non-human cells, cell parts and generated biogenic and released parts that are designed for medical diagnosis, prevention, therapy and predictive medicine; veterinary apparatus and instruments for preparation, injection, engraftment or use of non-human cells, cell parts and generated biogenic and released parts, namely, syringes that are designed for veterinary diagnosis, prevention, therapy and predictive medicine; artificial limbs, eyes and teeth from engineered cells; orthopedic apparatus and instruments for preventive and therapeutic medicine; suture materials from engineered cells; all of the foregoing are for medical purposes
Pharmaceutical and biological products, namely, preparations of human or non-human cells, cell parts and generated biogenic and released parts for medical diagnosis, prevention, therapy and predictive medicine unrelated to brain disorders; veterinary products, namely, preparations of non-human cells, cell parts and generated biogenic and released parts for animal therapy unrelated to brain disorders; sanitary products for use in medicine, namely, sanitary preparations for medical use; dietetic food and substances adapted for medical or veterinary use, namely, liquid or dehydrated solutions derived from preparations of biogenic and released parts from engineered cells; dietary supplements for humans and animals, namely, preparations of biogenic and released parts from engineered cells; medical plasters, materials for dressings in the nature of medical and surgical dressings derived from preparations of human or non-human cells, cell parts and generated biogenic and released parts; disinfectants, namely, preparations of human or non-human cells, cell parts and generated biogenic and released parts for hygiene purposes, sanitary purposes and inhibition of pathogens growth; pesticides generated by engineered cells; fungicides and herbicides generated by engineered cells; all of the foregoing are for medical purposes
No 79128131
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 27th Aug 2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| 26th Aug 2023 | DEATH OF INTERNATIONAL REGISTRATION |
| 04th Dec 2020 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 05th Jan 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 19th Dec 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 19th Dec 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| 19th Dec 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 19th Dec 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 19th May 2017 | NON-FINAL ACTION WRITTEN |
| 19th May 2017 | NON-FINAL ACTION E-MAILED |
